G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 99 filers reported holding G1 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $336,960 | -42.2% | 234,000 | 0.0% | 0.06% | -40.6% |
| Q2 2023 | $582,660 | -7.1% | 234,000 | 0.0% | 0.10% | -11.1% |
| Q1 2023 | $627,120 | -37.2% | 234,000 | +27.2% | 0.11% | -40.3% |
| Q4 2022 | $999,120 | -40.3% | 184,000 | +37.3% | 0.18% | -44.8% |
| Q3 2022 | $1,673,000 | +152.7% | 134,000 | 0.0% | 0.33% | +164.5% |
| Q2 2022 | $662,000 | -45.6% | 134,000 | -16.2% | 0.12% | -29.5% |
| Q1 2022 | $1,216,000 | +3.6% | 160,000 | +39.1% | 0.18% | +19.7% |
| Q4 2021 | $1,174,000 | -1.2% | 115,000 | +29.9% | 0.15% | -7.5% |
| Q3 2021 | $1,188,000 | +97.0% | 88,500 | +221.8% | 0.16% | +80.7% |
| Q2 2021 | $603,000 | +25.4% | 27,500 | +37.5% | 0.09% | +33.3% |
| Q1 2021 | $481,000 | +48.5% | 20,000 | +11.1% | 0.07% | +22.2% |
| Q4 2020 | $324,000 | – | 18,000 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 994,287 | $19,041,000 | 1.55% |
| HHLR ADVISORS, LTD. | 949,431 | $18,182,000 | 0.75% |
| BB BIOTECH AG | 671,925 | $12,867,000 | 0.41% |
| Rhenman & Partners Asset Management AB | 172,820 | $3,310,000 | 0.38% |
| Birchview Capital, LP | 15,000 | $287,000 | 0.27% |
| Rock Springs Capital Management LP | 100,000 | $1,915,000 | 0.09% |
| SECOR Capital Advisors, LP | 32,591 | $624,000 | 0.08% |
| MARSHALL WACE, LLP | 386,510 | $7,402,000 | 0.08% |
| SIGNATUREFD, LLC | 37,942 | $727,000 | 0.07% |
| A.R.T. Advisors, LLC | 38,125 | $730,000 | 0.05% |